Reconstructing tumor history in breast cancer: signatures of mutational processes and response to neoadjuvant chemotherapy von Denkert, C., Untch, M., Benz, S., Schneeweiss, A., Weber, K.E., Schmatloch, S., Jackisch, C., Sinn, H.P., Golovato, J., Karn, T., Marmé, F., Link, T., Budczies, J., Nekljudova, V., Schmitt, W.D., Stickeler, E., Müller, V., Jank, P., Parulkar, R., Heinmöller, E., Sanborn, J.Z., Schem, C., Sinn, B.V., Soon-Shiong, P., van Mackelenbergh, M., Fasching, P.A., Rabizadeh, S., Loibl, S.

Volltext

P-038MET activation via exon 14 skipping mutations (METex14del): gastrointestinal prevalence and sensitivity to MET inhibitor AMG337 von Cecchi, F, Rabizadeh, S, Weingarten, P, Tsai, C, Zhou, L, Hembrough, T

Volltext

Identifying patient-specific neoepitopes for cell-based and vaccine immunotherapy within The Cancer Genome Atlas reveals rarely shared recurrent neoepitopes von Nguyen, A, Sanborn, J.Z, Vaske, C, Rabizadeh, S, Niazi, K, Soon-Shiong, P, Benz, S

Volltext

Receptors that mediate cellular dependence von Bredesen, D E, Mehlen, P, Rabizadeh, S

Volltext

Mutations Associated with Amyotrophic Lateral Sclerosis Convert Superoxide Dismutase from an Antiapoptotic Gene to a Proapoptotic Gene: Studies in Yeast and Neural Cells von Rabizadeh, Shahrooz, Gralla, Edith Butler, Borchelt, David R., Gwinn, Ryder, Valentine, Joan Selverstone, Sisodia, Sangram, Wong, Philip, Lee, Michael, Hahn, Hejin, Bredesen, Dale E.

Volltext

A30 Tumor-Infiltrating Lymphocytes (TILs) Found Elevated in Lung Adenocarcinomas (LUAD) Using Automated Digital Pathology Masks Derived from Deep-Learning Models von Jaber, M.I., Beziaeva, L., Benz, S.C., Reddy, S.K., Rabizadeh, S., Szeto, C.W.

Volltext

P181 infliximab exposure during induction associate with time to remission and disease control of inflammatory bowel disease von Laharie, D, Rabizadeh, S, D’Haens, G, Dubinsky, M, Panetta, J C, Everts-van der Wind, A, Dreesen, E, Spencer, E, Vermeire, S, Dervieux, T

Volltext

PS5 New Biomarkers to Follow Therapy Response in Plasma of NSCLC Patients von Raez, L., Usher, J., Danenberg, K., Habaue, C., Jaimes, Y., Hunis, B., Rabizadeh, S., Danenberg, P.

Volltext

P1.01-68 Monitoring Clinical Responses Measuring PD-L1 in cfRNA in Plasma of Non-Small Cell Lung Cancer Patients Undergoing Systemic Therapy von Raez, L., Usher, J., Danenberg, K., Sumarriva, D., Hunis, B., Domingo, G., Jaimes, Y., Danenberg, P., Rabizadeh, S.

Volltext

Expression of the Baculovirus p35 Gene Inhibits Mammalian Neural Cell Death von Rabizadeh, S., LaCount, D. J., Friesen, P. D., Bredesen, D. E.

Volltext

358PComplete responses in patients with second-line or greater metastatic triple negative breast cancer (TNBC) following first-in-human immunotherapy combining NK and T cell activa... von Nangia, C, Soon-Shiong, P, Rabizadeh, S, Lee, J H, Sender, L, Jones, F, Kistler, M, Niazi, K, Seery, T, Rock, A, Jafari, O

Volltext

358P - Complete responses in patients with second-line or greater metastatic triple negative breast cancer (TNBC) following first-in-human immunotherapy combining NK and T cell act... von Nangia, C., Soon-Shiong, P., Rabizadeh, S., Lee, J.H., Sender, L., Jones, F., Kistler, M., Niazi, K., Seery, T., Rock, A., Jafari, O.

Volltext

Complete responses in patients with second-line or greater metastatic triple negative breast cancer (TNBC) following first-in-human immunotherapy combining NK and T cell activation... von Nangia, C., Soon-Shiong, P., Rabizadeh, S., Lee, J.H., Sender, L., Jones, F., Kistler, M., Niazi, K., Seery, T., Rock, A., Jafari, O.

Volltext

Abstract P2-04-10: High-affinity activated natural killer (haNK) cells augment trastuzumab efficacy in a mouse model of HER2-positive human metastatic breast cancer von Rabizadeh, S, Zhou, L, Toneguzzo, F, Boissel, L, Soon-Shiong, P, Niazi, K, Klingemann, H

Volltext

Expression of the Low-Affinity Nerve Growth Factor Receptor Enhances β-Amyloid Peptide Toxicity von Rabizadeh, Shahrooz, Bitler, Catherine M., Butcher, Larry L., Bredesen, Dale E.

Volltext

319 - Identifying patient-specific neoepitopes for cell-based and vaccine immunotherapy within The Cancer Genome Atlas reveals rarely shared recurrent neoepitopes von Nguyen, A., Sanborn, J.Z., Vaske, C., Rabizadeh, S., Niazi, K., Soon-Shiong, P., Benz, S.

Volltext

In-situ diversification of immunity following vaccination targeting tumor neoepitopes; an integral component of combinatorial immunotherapy von Lee, K.L., Palena, C., Lee, J., Niazi, K., Nguyen, A., Benz, S.C., Su, Z., Rabizadeh, S., Soon-Shiong, P., Schlom, J., Hamilton, D.H.

Volltext

Identification of a Novel Ras-Regulated Proapoptotic Pathway von Khokhlatchev, Andrei, Rabizadeh, Shahrooz, Xavier, Ramnik, Nedwidek, Maria, Chen, Tao, Zhang, Xian-feng, Seed, Brian, Avruch, Joseph

Volltext

OA 18.04 Whole Genome Tumor-Normal Sequencing Reveals Potential False Positives Versus Standard CGP Sequencing in Patients with NSCLC von Sanborn, J.Z., Benz, S., Garner, C., Soon-Shiong, P., Rabizadeh, S., Reddy, S.

Volltext

MA19.06 Blood Based Biomarkers: RNA, KRAS and PD-L1 Strongly Matching with Tissue and Showing Correlation with Clinical Responses In NSCLC Patient’s von Raez, L., Usher, J., Habaue, C., Danenberg, K., Hunis, B., Jaimes, Y., Rabizadeh, S., Castrellon, A., Danenberg, P.

Volltext